And thank you for joining us to discuss our fourth quarter and full year 2025 results. Earlier this month, our industry ...
Castle Biosciences (NASDAQ:CSTL) reported fourth-quarter revenue of $87.0 million and full-year 2025 revenue of $344.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results